Search Orphan Drug Designations and Approvals
-
Generic Name: | rencofilstat |
---|---|
Date Designated: | 06/17/2022 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hepion Pharmaceuticals, Inc. 399 Thornall Street, First Floor Edison, New Jersey 08837 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-